AzTrials
AzTrials

Axial SpondyloarthritisNCT06230952

Reliability of BASDAI and BASFI Applied by Tele-Assessment Method in Axial SpA Spondyloarthritis

An observational study of Axial Spondyloarthritis, run by Siirt University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this observational study is to investigate the reliability of BASDAI and BASFI questionnaires applied via tele-assessment in axial spondyloarthritis patients. Read more about this study

Who is it for?
Ages 20 to 60 years
Conditions the study is for
Axial Spondyloarthritis
What is being tested?
BASDAI and BASFI reliability
How many people
102 participants
Where
1 siteTurkey (Türkiye)
Study dates
8 Feb 2024to 27 May 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: It was planned to include at least 100 axial SpA patients in the study.

Who may be able to join

  • Being diagnosed with Axial spondyloarthritis according to the Assessment in SpondyloArthritis international Society (ASAS) criteria
  • Volunteering to participate in the study
  • Being between the ages of 20-60

Who cannot join

  • Having another systemic, orthopedic, neurological or cognitive disease other than axial spondyloarthritis
  • Pregnancy
  • The patient wishes to withdraw from the study

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Dokuz Eylül University

    Izmir

Other trials in Turkey (Türkiye)

About this study

Official title: Reliability of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Bath Ankylosing Spondylitis Functional Index (BASFI) Applied by Tele-Assessment Method in Patients With Axial Spondyloarthritis

The goal of this observational study is to investigate the reliability of BASDAI and BASFI questionnaires applied via tele-assessment in axial spondyloarthritis patients.

Read the detailed description

Telehealth is the provision of healthcare services and clinical practices remotely through information and communication technologies. In recent years, the use of telehealth applications has increased worldwide. Telehealth is an umbrella term that covers practices such as telemedicine, telerehabilitation, and tele-assessment. Tele-assessment has gained importance in terms of monitoring patients with chronic diseases. Although BASDAI and BASFI have been shown to be valid and reliable in AS patients, there is no study in the literature examining the reliability of BASDAI and BASFI applied via tele-assessment. The aim of our study is to investigate the reliability of BASDAI and BASFI questionnaires administered via tele-assessment in axial SpA patients.

Being tested
BASDAI and BASFI reliability
Keywords
axial spondyloarthritis, BASDAI, BASFI, self assessment, tele-assessment, reliability
Medical subject headings
Axial Spondyloarthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BASDAI and BASFI reliabilityOther

    The study will be carried out on volunteer patients who are diagnosed with axial spondyloarthritis and are followed up in the outpatient clinic of Dokuz Eylül University, Department of Internal Medicine, Rheumatology and Immunology Department, and who meet the inclusion criteria. Patients who volunteer to participate in the study will be contacted by phone and BASDAI and BASFI questionaires will be administered.

Study groups in NCT06230952
Study groupRoleWhat they receive
axial spondyloarthritis patientspatients diagnosed with axial spondyloarthritis
Receives: Other: BASDAI and BASFI reliability

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)

    Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) is a reliable and sensitive index developed to evaluate the activity and progression of the disease. The BASDAI is a 6-item composite index that measures fatigue, neck, back, hip pain, peripheral joint pain/swelling, and morning stifness. The final BASDAI score ranges from 0 to 10, and higher scores represent higher disease activity.

    Measured: Baseline and after 24 hours after baseline assessment

  2. Bath Ankylosing Spondylitis Functional Index (BASFI)

    BASFI is an easy-to-apply, sensitive and reliable self-report questionnaire developed to evaluate physical function in AS patients. It consists of a total of 10 items, eight assessing functionality and two assessing the patient's ability to cope with daily life. The BASFI Score is the avarage of the 10 items and ranges between 0 and 10, with higher scores indicating greater functional limitation.

    Measured: Baseline and after 24 hours after baseline assessment

Secondary outcomes (6)
  1. Age

    Age in years

    Measured: Baseline

  2. Disease duration

    Disease duration in years

    Measured: Baseline

  3. Medications

    The medications used by patients will be recorded

    Measured: Baseline

  4. weight

    weight (kg)

    Measured: Baseline

  5. height

    height (m)

    Measured: Baseline

  6. Education

    Education level of patients will be recorded

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2024
  2. Study start8 Feb 2024
  3. Primary completion27 May 2024
  4. Study completion27 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
102 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06230952
Sponsor's protocol ID
2023/39-19
Status last verified
May 2024
First submitted
16 Jan 2024
Last updated
29 May 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Acar Y, Ilcin N, Sari I. Reliability of the Bath Ankylosing Spondylitis Disease Activity Index and the Bath Ankylosing Spondylitis Functional Index administered via tele-assessment in patients with axial spondyloarthritis. Physiother Theory Pract. 2025 Dec;41(12):2585-2594. doi: 10.1080/09593985.2025.2536319. Epub 2025 Jul 21.

    PubMed 40686331

Questions about this trial

What is this clinical trial studying?

An observational study of Axial Spondyloarthritis, run by Siirt University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) (time frame: Baseline and after 24 hours after baseline assessment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06230952, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in